CHRS · Congress trades
See corporate insider trades for CHRS →
Trades by members of Congress
| Member | Party | Owner | Ticker | Asset | Type | Amount range | Traded | Disclosed | Delay | |
|---|---|---|---|---|---|---|---|---|---|---|
| Shri Thanedar Rep | D-MI | Self | CHRS | Coherus BioSciences, Inc. (CHRS) | Sale | $15.0K – $50.0K | 2023-01-23 | 2023-02-09 | 17d | PDF↗ |
Public-interest transparency data from official U.S. House Clerk STOCK Act disclosures (periodic transaction reports). Amounts are disclosed as ranges (e.g. $1,001–$15,000), not exact values, and members may report a trade up to 45 days after it happens — so recent activity can be missing. Trades flagged LATE were reported after 45 days. Scanned paper filings are linked but not parsed. Senate eFD ingest is not available yet.